Acute Effects of 2C-E in Humans: An Observational Study

Esther Papaseit, Eulalia Olesti, Clara Pérez-Mañá*, Marta Torrens, Marc Grifell, Mireia Ventura, Oscar J Pozo, Elizabeth B. de Sousa Fernandes Perna, Johannes G. Ramaekers, Rafael de la Torre, Magí Farré

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)

Abstract

2,5-Dimethoxy-4-ethylphenethylamine (2C-E) is psychedelic phenylethylamine, with a chemical structure similar to mescaline, used as new psychoactive substance (NPS). It inhibits norepinephrine and serotonin uptake and, more relevant, acts as a partial agonist of the serotonin 2A (5-HT2A), 2B (5-HT2B), and (5-HT2C) receptors. Consumers have reported that 2C-E induces mild-moderate psychedelic effects, but its pharmacology in humans, including pharmacological effects and pharmacokinetics, have not yet studied. To assess the acute effects of 2C-E on physiological and subjective effects and evaluate its pharmacokinetics, an observational study was carried-out. Ten recreational users of psychedelics self-administered a single oral dose of 2C-E (6.5, 8, 10, 15, or 25 mg). Blood pressure and heart rate were evaluated at baseline, 2, 4, and 6 h post-administration. Three rating scales were administered to evaluate subjective effects: a set of Visual Analog Scales (VAS), the 49-item short form version of the Addiction Research Centre Inventory (ARCI), and the Evaluation of the Subjective Effects of Substances with Abuse Potential (VESSPA-SSE) at baseline, 2, 4, and 6 h after self-administration. To assess 2C-E concentrations oral fluid (saliva) was collected during 6 h. 2C-E induced primarily alterations in perceptions, hallucinations, and euphoric-mood. Saliva maximal concentrations were achieved 2 h after self-administration. Administration of oral 2C-E at recreational doses produces a group of psychedelic-like effects such to 2C-B and other serotonin-acting drugs.

Original languageEnglish
Article number233
Number of pages13
JournalFrontiers in Pharmacology
Volume11
DOIs
Publication statusPublished - 18 Mar 2020

Keywords

  • 2C-E (2
  • 5-Dimethoxy-4-ethylphenethylamine)
  • novel psychoactive substances (NPS)
  • psychedelic
  • phenylethylamines
  • psychostimulants
  • PSYCHOACTIVE SUBSTANCE USE
  • REGULAR PSYCHOSTIMULANT USERS
  • HUMAN PHARMACOLOGY
  • BEVERAGE AYAHUASCA
  • ECSTASY
  • 3,4-METHYLENEDIOXYMETHAMPHETAMINE
  • EXPERIENCES
  • RECEPTOR
  • SAMPLE

Cite this